Following concerns from hospitals regarding an apparent change to its ER coverage policy, the payer clarified no changes were made — or will be made — to how it approves or denies its members’ emergency claims.
HCA continues to double down on the Florida market where it has invested $3 billion over the last three years.
The agency granted emergency use authorizations to both companies’ over-the-counter diagnostics under a new accelerated review program. However, it may take months for them to scale up production.
The justices will hear arguments on the requirement that healthcare workers must be fully vaccinated, amid a flurry of legal challenges.
This is the second billion-dollar deal with SurgCenter Development in as many years as Tenet continues building out its surgery center footprint, a key component of its long-term strategy.
Ashley McEvoy is confident that 2022 will not be as bad as the first or second year of the COVID-19 pandemic, even as the omicron variant drives cases up, but adds that “we’re not out of the woods yet.”
Paxlovid is the first oral treatment for COVID-19, a potentially valuable new tool as the fast-spreading omicron variant fuels a sharp surge in cases across the U.S.
Effective Jan. 1, the average list price for Aduhelm will drop about 50% to just over $28,000 a year. It’s a move the company hopes will appease insurers and lower out-of-pocket costs for patients.
Soon, the payer will begin searching for Michael Neidorff’s successor, kicking off an executive search for the first time since he was installed in 1996.
The high court blocked a challenge to New Mexico’s statewide vaccine mandate for healthcare workers Tuesday. The CMS vaccine mandate remains in place, though injunctions in some states still stand.